2500059 part 2

Study for the treatment of atopic eczema (Part 2)

18-55
  • Male
  • Female
September - December
7 to 14 days
17
3700

Are you

  • a healthy man or woman
  • between 18 and 55 years (inclusive)
  • with a BMI between 18.0 and 30.0 kg/m² (inclusive) 
    • weighing between 45.0 and 100.0 kg (inclusive)
  • who does not smoke or smokes a maximum of 10 cigarettes per week and is willing to quit smoking during the study
  • and does not use daily medication

What does this trial involve?

In study 2500059 part 2, SGS CPU is investigating the treatment of atopic eczema. During +/- 18 weeks you will have the following appointments:

  • a screening visit
  • 2 stays consisting of 4 days (3 nights) + one stay of 3 days (2 nights)
  • 16 morning return visits
  • an end of trial visit

Take part in this trial and

  • contribute to the medicine of tomorrow
  • a compensation will be provided

This study was approved by the competent Belgian health authorities and an independent ethics committee.

View information leaflet Part 2 cohort 2

View study dates Part 2 cohort 2

Any other questions?

Ask your question